Press Release

President Muhammadu Buhari signs bill for an act to establish the Nigeria Centre for Disease Control

1 Mins read

As a demonstration of his commitment to national health security, the President of the Federal Republic of Nigeria, Muhammadu Buhari, has signed the Bill for an Act to establish the Nigeria Centre for Disease Control (NCDC).

Since its establishment in 2011, NCDC has demonstrated its capacity to protect the health of Nigerians by delivering on its core functions of preparedness, detection and response to outbreaks of infectious diseases.

This new Act which will establish NCDC as a full-fledged parastatal, will also ensure that its valuable work is sustained and supported. The Chief Executive of the agency, Dr. Chikwe Ihekweazu said “We are very grateful for Mr. President’s support in the passage of the Executive Bill. This Bill will provide Nigerians with an institute that has the capacity to ensure the country’s health security. We are also grateful to the Honourable Minister and Minister of State for Health for their support and the Senate Committee on Primary Health Care and Communicable Diseases led by Senator Mao Ohuabunwa.”

With the passage of the Bill establishing Nigeria’s national public health institute, the Federal Government of Nigeria has shown its commitment in ensuring Nigerians are well protected from the public health threat of global emerging infectious diseases. ABOUT NCDC The Nigeria Centre for Disease Control (NCDC) was established in the year 2011 in response to the challenges of public health emergencies and to enhance Nigeria’s preparedness and response to epidemics through prevention, detection, and control of communicable diseases. Its core mandate is to detect, investigate, prevent and control diseases of national and international public health importance.

Related posts
Press Release

CEPI backs updated Zaire ebolavirus vaccine that aims to improve vaccine affordability and accessibility for low- and middle-income countries

5 Mins read
GENEVA/OSLO/21 JAN: A vaccine used to help protect against Zaire ebolavirus – one of the world’s most severe infectious diseases – could become more…
Press Release

Oxford University enters into licensing arrangement with Serum Institute of India to develop Rift Valley fever vaccine candidate

6 Mins read
Serum Institute of India to make up to 100,000 investigational Oxford Rift Valley fever vaccine doses. Rift Valley fever is a potentially…
Press Release

NIGERIA AND UNITED STATES SIGN LANDMARK AGREEMENT TO STRENGTHEN HEALTH SECURITY, EXPAND PRIMARY CARE, AND DRIVE SELF-RELIANCE

2 Mins read
The Government of the Federal Republic of Nigeria and the Government of the United States of America today signed a landmark technical…

Leave a Reply

Your email address will not be published. Required fields are marked *